The Infectious Diseases Society of America has released its first guidelines on treating methicillin-resistant Staphylococcus aureus (MRSA) infections.
The guidelines, published in Clinical Infectious Diseases, cover the following areas:
- management of common clinical syndromes linked to MRSA infections, such as bacteremia, endocarditis, pneumonia, and infections of the skin, soft tissue, central nervous system, bones, and joints;
- vancomycin dosing and monitoring;
- limitations of vancomycin susceptibility tests;
- adjunctive therapies in cases of vancomycin failure or reduced susceptibility to the drug;
- oral antibiotic options.
